{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:06:42Z","timestamp":1762909602138,"version":"3.45.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.resmer.2023.101038","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T21:27:09Z","timestamp":1688506029000},"page":"101038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparison of amikacin lung delivery between AKITA\u00ae and eFlow rapid\u00ae nebulizers in healthy controls and patients with CF: A randomized cross-over trial"],"prefix":"10.1016","volume":"84","author":[{"given":"Anne-Sophie","family":"Aubriot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Maerckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresinha","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Gohy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7674-1150","authenticated-orcid":false,"given":"Gregory","family":"Reychler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resmer.2023.101038_bib0001","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jcf.2014.03.010","article-title":"European Cystic Fibrosis Society Standards of Care: best practice guidelines","volume":"13","author":"Smyth","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resmer.2023.101038_bib0002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.addr.2018.06.006","article-title":"Repurposing drugs as inhaled therapies in asthma","volume":"133","author":"Anderson","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.resmer.2023.101038_bib0003","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/164_2016_67","article-title":"Drug delivery devices for inhaled medicines","volume":"237","author":"Lexmond","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.resmer.2023.101038_bib0004","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1378\/chest.110.2.498","article-title":"Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand","volume":"110","author":"Hess","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.resmer.2023.101038_bib0005","first-page":"1406","article-title":"Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol","volume":"47","author":"Dhand","year":"2002","journal-title":"Respir Care"},{"issue":"2","key":"10.1016\/j.resmer.2023.101038_bib0006","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4155\/tde-2017-0102","article-title":"Mesh nebulizers have become the first choice for new nebulized pharmaceutical drug developments","volume":"9","author":"Pritchard","year":"2018","journal-title":"Ther Deliv"},{"issue":"2","key":"10.1016\/j.resmer.2023.101038_bib0007","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1183\/09031936.00118408","article-title":"Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency","volume":"34","author":"Brand","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2023.101038_bib0008","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1183\/09031936.03.00096802","article-title":"Peripheral deposition of alpha1-protease inhibitor using commercial inhalation devices","volume":"22","author":"Brand","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2023.101038_bib0009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/jam.2005.18.45","article-title":"Optimum peripheral drug deposition in patients with cystic fibrosis","volume":"18","author":"Brand","year":"2005","journal-title":"J Aerosol Med"},{"key":"10.1016\/j.resmer.2023.101038_bib0010","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/(SICI)1520-6017(200006)89:6<724::AID-JPS3>3.0.CO;2-B","article-title":"Total deposition of therapeutic particles during spontaneous and controlled inhalations","volume":"89","author":"Brand","year":"2000","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.resmer.2023.101038_bib0011","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1164\/ajrccm.156.5.9604093","article-title":"RhDNase I aerosol deposition and related factors in cystic fibrosis","volume":"156","author":"Diot","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2023.101038_bib0012","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2281.1999.00170.x","article-title":"The effect of breathing frequency on deposition of drug aerosol using an inhalation-synchronized dosimeter in healthy adults","volume":"19","author":"Hakkinen","year":"1999","journal-title":"Clin Physiol"},{"key":"10.1016\/j.resmer.2023.101038_bib0013","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1089\/jamp.2009.0786","article-title":"Mode of breathing-tidal or slow and deep-through the I-neb Adaptive Aerosol Delivery (AAD) system affects lung deposition of (99m)Tc-DTPA","volume":"23","author":"Nikander","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.resmer.2023.101038_bib0014","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1136\/thx.52.2008.S92","article-title":"Selecting and using nebuliser equipment","volume":"52","author":"Kendrick","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.resmer.2023.101038_bib0015","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1183\/09031936.01.99086801","article-title":"Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis","volume":"18","author":"Dequin","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2023.101038_bib0016","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archinte.1959.00270070017003","article-title":"Kanamycin 2 AMA","volume":"104","author":"Finegold","year":"1959","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.resmer.2023.101038_bib0017","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/cpt1974156610","article-title":"Comparative pharmacokinetics of amikacin and kanamycin 101","volume":"15","author":"Clarke","year":"1974","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.resmer.2023.101038_bib0018","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2016.09.064","article-title":"Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation","volume":"181S","author":"Farrell","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.resmer.2023.101038_bib0019","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An Official American Thoracic Society and European Respiratory Society Technical Statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2023.101038_bib0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/jamp.2010.0816","article-title":"Delivery efficacy of a vibrating mesh nebulizer and a jet nebulizer under different configurations","volume":"23","author":"Pitance","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.resmer.2023.101038_bib0021","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1089\/jamp.2015.1243","article-title":"In vitro comparison of a vibrating mesh nebulizer operating in inspiratory synchronized and continuous nebulization modes during noninvasive ventilation","volume":"29","author":"Michotte","year":"2016","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"1\u20132","key":"10.1016\/j.resmer.2023.101038_bib0022","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijpharm.2016.02.005","article-title":"Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients","volume":"502","author":"Buttini","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.resmer.2023.101038_bib0023","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2125.1986.tb02905.x","article-title":"The pharmacokinetics of sodium cromoglycate in man after intravenous and inhalation administration","volume":"22","author":"Neale","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.resmer.2023.101038_bib0024","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11096-014-0043-6","article-title":"Factors affecting nebulised medicine adherence in adult patients with cystic fibrosis: a qualitative study","volume":"37","author":"Hogan","year":"2015","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.resmer.2023.101038_bib0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pec.2008.08.027","article-title":"Adherence to nebulised antibiotics in cystic fibrosis","volume":"75","author":"Latchford","year":"2009","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.resmer.2023.101038_bib0026","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcf.2010.08.019","article-title":"Lung deposition of inhaled tobramycin with eFlow rapid\/LC Plus jet nebuliser in healthy and cystic fibrosis subjects","volume":"10","author":"Lenney","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resmer.2023.101038_bib0027","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/2047-783X-16-2-63","article-title":"Lung function in adult patients with cystic fibrosis after using the eFlow rapid for one year","volume":"16","author":"Naehrig","year":"2011","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.resmer.2023.101038_bib0028","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/jamp.2008.0712","article-title":"Changes in performance of the Pari eFlow rapid and Pari LC Plus during 6 months use by CF patients","volume":"22","author":"Rottier","year":"2009","journal-title":"J Aerosol Med Pulm Drug Deliv"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041223000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041223000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:04:00Z","timestamp":1762909440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041223000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":28,"alternative-id":["S2590041223000508"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2023.101038","relation":{},"ISSN":["2590-0412"],"issn-type":[{"type":"print","value":"2590-0412"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of amikacin lung delivery between AKITA\u00ae and eFlow rapid\u00ae nebulizers in healthy controls and patients with CF: A randomized cross-over trial","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2023.101038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 SPLF and Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101038"}}